Disclosed is an apparatus and method for providing asymmetric oscillations to a container. The container may include a fluid, a particle, and/or a gas. A vibration driver attached to the container provides asymmetric oscillations. A controller connected to the vibration driver controls an amplitude, frequency, and shape of the asymmetric oscillations. An amplifier amplifies the asymmetric oscillations in response to the controller. A sensor disposed on the vibration driver provides feedback to the controller.

Provided in one embodiment is a method of making, comprising: exposing a raw material having a first viscosity to a first pressure and a first temperature such that the raw material after the exposure has a second viscosity, wherein the raw material comprises particles comprising at least one electrically conductive material, and wherein the second viscosity is sufficiently low for the raw material to be adapted for a hydrodynamic cavitation process; and subjecting the raw material having the second viscosity to the hydrodynamic cavitation process to make a product material having a third viscosity. Apparatus employed to apply the method and the exemplary compositions made in accordance with the method are also provided.

A drug container is arranged in a horizontal state where a central axis extends along a horizontal direction, and the drug container is rotated about the central axis. In such a way, a drug solution in the drug container is moved along an inner surface of the drug container, and the drug container is reciprocally vibrated along the central axis in a state where the drug container is rotated, to stir the drug solution.

Disclosed is an apparatus and method for providing asymmetric oscillations to a container. The container may include a fluid, a particle, and/or a gas. A vibration driver attached to the container provides asymmetric oscillations. A controller connected to the vibration driver controls an amplitude, frequency, and shape of the asymmetric oscillations. An amplifier amplifies the asymmetric oscillations in response to the controller. A sensor disposed on the vibration driver provides feedback to the controller.

The present invention relates to a method of producing a wood and textile fibre protection composition from tall oil pitch. The present invention also relates to a wood and textile fibre protection composition comprising tall oil pitch and use of the composition as a wood and textile fibre protection agent.

Disclosed is a method for preparing a stable fluid mixture by mixing hydrophilic and hydrophobic substances using ultrasound wherein homogeneous dispersion and mixing are possible so that dispersibility is greatly improved and separation between the hydrophilic and hydrophobic substances is minimized even after a long time.

The apparatus for dispersing and mixing fluids by focused ultrasound includes a fluid storage unit for storing a fluid mixture of at least two fluids comprising a hydrophilic substance and a hydrophobic substance, the fluid storage unit comprising a first connector and a second connector connected to a fluid flow path such that the fluid mixture moves through a fluid flow path providing a portion through which the fluid mixture moves, a fluid dispersion unit for focusing ultrasound to a portion of the fluid flow path to disperse fluids contained in the fluid mixture by ultrasound when the fluid mixture moves the portion, and a fluid circulation unit for circulating the fluid mixture such that a portion of the fluid mixture relatively insufficiently dispersed is moved through the first connector from the fluid storage unit to the fluid dispersion unit and the fluid mixture dispersed by the fluid dispersion unit is moved through the second connector to the fluid storage unit.

An apparatus for mitigating contamination in a fuel supply is an ultrasonic generator coupled with a piezoelectric transducer that propagates ultrasonic waves through a fuel tank. In some embodiments the apparatus is used to mitigate the growth of microbial organisms. In other embodiments the apparatus is used to emulsify water into the fuel, particularly in diesel fuel. The apparatus addresses water and microbial growth found in boats, cars, and aircraft as well as in storage tanks such as those used at fuel stations. In some embodiments, the fluid is diesel fuel.

A highly stable cannabinoid nanoparticle carrier composition for administration to a human made by incorporating non-ionic surfactants with cannabinoid oils and lipids, sonicating for a predetermined period of time at a predetermined amplification with an ultrasonic liquid processor until completely integrated; combining the mixture with a carrier fluid that includes ascorbic acid and distilled water; and further sonicating the mixture using an ultrasonic liquid processor at predetermined amplitude for a predetermined period of time at a controlled temperature, and thereby to create a CBD nanoemulsion. The composition is tailored using non-ionic surfactants to adsorb to the surface of the cannabinoid oil particles to advantageously affect electrokinetics and surface forces at the interface of the bioactive cannabinoid particles and the suspending liquid are controlled by tailoring the suspending liquid to maximize the zeta potential.

Provided in one embodiment is a method of making, comprising: exposing a raw material having a first viscosity to a first pressure and a first temperature such that the raw material after the exposure has a second viscosity, wherein the raw material comprises particles comprising at least one electrically conductive material, and wherein the second viscosity is sufficiently low for the raw material to be adapted for a hydrodynamic cavitation process; and subjecting the raw material having the second viscosity to the hydrodynamic cavitation process to make a product material having a third viscosity. Apparatus employed to apply the method and the exemplary compositions made in accordance with the method are also provided.

A method for improving stability and/or absorption of one or more biologically active agents including preparing formulations wherein a biologically active agent is dispersed using a homogenizer and/or a nanofluidizer; and optionally: i) enriching the formulation; and/or ii) delivering the formulations to a subject whereby the biologically active agent is absorbed by said subject, and/or iii) testing the formulation to identify suitable dosing ranges using computational modeling of biomolecular pathways to determine at least one feature selected from absorption in a cell, saturation of a cell, and potential toxicity in a cell, and/or iv) testing the formulation by monitoring with a low impact, minimally intrusive heart rate variability monitoring to enable rapid determination of neurological and physiological effects of a dosage, establishing dosing levels of the biologically active agent, and/or v) defining the corresponding metabolic effects of the dosage of the biologically active agent on the subject.